(E)-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methylidene)[(2,4-dichlorophenyl)methoxy]amine

Catalog No. :
ACZMQK496
CAS No. :
478257-33-9
Molecular Formula :
C21H14Cl3N3O
Molecular Weight :
430.72

IUPAC Name:(E)-6-chloro-2-phenylimidazo[1,2-a]pyridine-3-carbaldehyde O-(2,4-dichlorobenzyl) oxime

(E)-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methylidene)[(2,4-dichlorophenyl)methoxy]amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methylidene)[(2,4-dichlorophenyl)methoxy]amine
IUPAC Name(E)-6-chloro-2-phenylimidazo[1,2-a]pyridine-3-carbaldehyde O-(2,4-dichlorobenzyl) oxime
MDL No.MFCD02102803
Molecular FormulaC21H14Cl3N3O
Molecular Weight430.72
SMILESClC1=CC=C(CO/N=C/C2=C(C3=CC=CC=C3)N=C4C=CC(Cl)=CN42)C(Cl)=C1
InChI KeyKAGPQUHCKDXDLY-OPEKNORGSA-N
Synonym6-CHLORO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE O-(2,4-DICHLOROBENZYL)OXIME;(E)-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methylidene)[(2,4-dichlorophenyl)methoxy]amine;Imidazo[1,2-a]pyridine-3-carboxaldehyde, 6-chloro-2-phenyl-, O-[(2,4-dichlorophenyl)methyl]oxime
CAS No.478257-33-9

Synthetic Route by SureRoute

1. ACZMQK496 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCTFQ746 route compound structure diagram
    ACCTFQ74651572-93-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZMQK496 route product structure diagram
    ACZMQK496478257-33-9
Inquiry

2. ACZMQK496 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZMQK496 route product structure diagram
    ACZMQK496478257-33-9
Inquiry

Comments (0)